Joan Leslie Walker, MD
Professor, James A. Merrill Chair, Gynecologic Oncology
The University of Oklahoma
Dept. of OB/GYN
800 NE 10th St
Suite 5050
Oklahoma City,
OK
USA
73104
Biographical Sketch: GOG Co-Chair cancer prevention and control. PI NCI SUCCEED BIOMARKERS IN CERVICAL CANCER. Currently driving toward ovarian cancer risk reduction with OCP And salpingectomy followed by oophorectomy in high risk women. Salpingectomy alone in average risk women.
Papers:
12 - Focused Plenary
Operative outcomes among a geriatric population of endometrial cancer patients: an ancillary data analysis of Gynecologic Oncology Group study LAP2
62 - Scientific Plenary
Ascites predicts degree of treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, Fallopian tube, and peritoneal cancers
76 - Focused Plenary
Complications and surgical staging of endometrial cancer with respect to obesity: a Gynecologic Oncology Group LAP2 ancillary data study
96 - Featured Poster
Patient and physician factors associated with participation in Gynecologic Oncology Group (GOG) trials in cervical and uterine cancer
118 - Featured Poster
Patterns of recurrence and survival after randomization to laparoscopy versus laparotomy in women with high-grade uterine cancer: a Gynecologic Oncology Group (GOG) study
139 - Scientific Plenary
Health-related quality of life associated with every-3-week paclitaxel vs dose-dense weekly paclitaxel in combination with carboplatin with or without bevacizumab for primary ovarian cancer: Gynecologic Oncology Group study 262
437 - Poster Session B
The impact of obesity on pathologic features and survival with endometrial cancer: a Gynecologic Oncology Group (GOG) LAP2 ancillary data study
Discussant